Immunomedics wins patent ruling

Article

Immunomedics of Morris Plains, NJ, said last month that the EuropeanPatent Office has issued a decision maintaining its patent forusing antibodies for carcinoembryonic antigen (CEA) that are effectivefor targeting tumors with imaging and therapy agents.

Immunomedics of Morris Plains, NJ, said last month that the EuropeanPatent Office has issued a decision maintaining its patent forusing antibodies for carcinoembryonic antigen (CEA) that are effectivefor targeting tumors with imaging and therapy agents. The patenthad been challenged by Behringwerke AG of Germany, which did notappeal the patent office's decision denying its request, accordingto Immunomedics. The company's stock jumped 24% after the patentnews was announced.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.